Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Fenbendazole

  • Open Access
    Fenbendazole and Diisopropylamine Dichloroacetate Exert Synergistic Anti-cancer Effects by Inducing Apoptosis and Arresting the Cell Cycle in A549 Lung Cancer Cells
    THAI Q. NGUYEN, DANG H. NGUYEN, UYEN T. T. PHAN, PHUONG T. T. TRAN, HUONG T. LE, SON H. NGUYEN, JOLIE NGUYEN, BO HAN and BA X. HOANG
    Anticancer Research November 2024, 44 (11) 4761-4772; DOI: https://doi.org/10.21873/anticanres.17302
  • Open Access
    Oral Fenbendazole for Cancer Therapy in Humans and Animals
    JOLIE NGUYEN, THAI Q. NGUYEN, BO HAN and BA X. HOANG
    Anticancer Research September 2024, 44 (9) 3725-3735; DOI: https://doi.org/10.21873/anticanres.17197
  • You have access
    Redox-mediated Anticancer Activity of Anti-parasitic Drug Fenbendazole in Triple-negative Breast Cancer Cells
    SEVERINA SEMKOVA, BILIANA NIKOLOVA, IANA TSONEVA, GEORGI ANTOV, DONIKA IVANOVA, ANTON ANGELOV, ZHIVKO ZHELEV and RUMIANA BAKALOVA
    Anticancer Research March 2023, 43 (3) 1207-1212; DOI: https://doi.org/10.21873/anticanres.16267
  • You have access
    Fenbendazole as a Potential Anticancer Drug
    QIWEN DUAN, YANFENG LIU and SARA ROCKWELL
    Anticancer Research February 2013, 33 (2) 355-362;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire